Literature DB >> 9585116

An update on the CNS actions of TRH and its analogs.

A Horita1.   

Abstract

This brief review will discuss the recent literature on several of the central actions of TRH and its analogs. The most prominent of these actions include: (1) the arousal or analeptic effect in drug narcotized animals or in concussion models; (2) the reversal of cognitive deficits produced by various drugs or procedures, and (3) the improvement of several neurological deficits produced in animal models of spinal and/or cerebellar injury. The mediation of these TRH effects by neurotransmitters is discussed. While little has been published on the human neuropsychopharmacology of TRH, and especially of its analogs, the future holds considerable therapeutic promise for these interesting drugs.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9585116     DOI: 10.1016/s0024-3205(98)00087-3

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  16 in total

1.  Distribution and axonal projections of neurons coexpressing thyrotropin-releasing hormone and urocortin 3 in the rat brain.

Authors:  Gábor Wittmann; Tamás Füzesi; Zsolt Liposits; Ronald M Lechan; Csaba Fekete
Journal:  J Comp Neurol       Date:  2009-12-20       Impact factor: 3.215

2.  Thyrotropin-releasing hormone (TRH) inhibits melanin-concentrating hormone neurons: implications for TRH-mediated anorexic and arousal actions.

Authors:  Xiaobing Zhang; Anthony N van den Pol
Journal:  J Neurosci       Date:  2012-02-29       Impact factor: 6.167

3.  Inhibition of prolactin secretion from the male rat anterior pituitary by cryptic sequences of prothyrotropin releasing hormone, ProTRH178-199 and ProTRH186-199.

Authors:  Thomas H Alexander; Robert J Handa; Robert F McGivern
Journal:  Endocrine       Date:  2002-12       Impact factor: 3.633

4.  Structure-activity studies with high-affinity inhibitors of pyroglutamyl-peptidase II.

Authors:  Julie A Kelly; Gaia A Scalabrino; Gillian R Slator; Aoife A Cullen; John F Gilmer; David G Lloyd; Geoffrey W Bennett; Karl Bauer; Keith F Tipton; Carvell H Williams
Journal:  Biochem J       Date:  2005-07-15       Impact factor: 3.857

5.  [Glu2]TRH dose-dependently attenuates TRH-evoked analeptic effect in mice.

Authors:  Vien Nguyen; Alevtina D Zharikova; Katalin Prokai-Tatrai; Laszlo Prokai
Journal:  Brain Res Bull       Date:  2010-02-24       Impact factor: 4.077

6.  Piracetam and TRH analogues antagonise inhibition by barbiturates, diazepam, melatonin and galanin of human erythrocyte D-glucose transport.

Authors:  Richard J Naftalin; Philip Cunningham; Iram Afzal-Ahmed
Journal:  Br J Pharmacol       Date:  2004-05-17       Impact factor: 8.739

7.  The role of Thyrotropin Releasing Hormone in aging and neurodegenerative diseases.

Authors:  Caitlin M Daimon; Patrick Chirdon; Stuart Maudsley; Bronwen Martin
Journal:  Am J Alzheimers Dis (Columbia)       Date:  2013

8.  Efferent projections of thyrotropin-releasing hormone-synthesizing neurons residing in the anterior parvocellular subdivision of the hypothalamic paraventricular nucleus.

Authors:  Gábor Wittmann; Tamás Füzesi; Praful S Singru; Zsolt Liposits; Ronald M Lechan; Csaba Fekete
Journal:  J Comp Neurol       Date:  2009-07-20       Impact factor: 3.215

Review 9.  Thyrotropin-releasing hormone (TRH) in the cerebellum.

Authors:  Nobuyuki Shibusawa; Koshi Hashimoto; Masanobu Yamada
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

10.  Chronic LSD alters gene expression profiles in the mPFC relevant to schizophrenia.

Authors:  David A Martin; Danuta Marona-Lewicka; David E Nichols; Charles D Nichols
Journal:  Neuropharmacology       Date:  2014-04-03       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.